Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients

Background/Aim: More than half of deaths among hemodialysis patients are due to cardiovascular disease. This study examined whether intravenous administration of ferric carboxymaltose (FCM) has an impact on cardiovascular events in iron-deficient hemodialysis patients. Patients and Methods: We perfo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:In Vivo
Autores principales: RIGHINI, MATTEO, DALMASTRI, VITTORIO, CAPELLI, IRENE, ORSI, CLAUDIO, DONATI, GABRIELE, PALLOTTI, MARIA GIOVANNA, PEDONE, CHIARA, CASELLA, GIANNI, CHIECO, PASQUALE, MANNA, GAETANO LA
Formato: Artigo
Lenguaje:Inglês
Publicado: International Institute of Anticancer Research 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8193293/
https://ncbi.nlm.nih.gov/pubmed/33910844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12419
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares